BUSINESS
April 28, 2012 | By Jerry Hirsch, Los Angeles Times
Ford Motor Co. will offer about 90,000 U.S. salaried retirees and former employees vested in its pension plan a lump-sum payment to buy them out of monthly benefits. Ford, which also reported lower first-quarter earnings Friday because of losses in Europe and Asia, said the plan was an innovative strategy to reduce its pension obligations. The automaker won't put up any operating cash but rather will make the one-time payments from existing pension plan assets. "We believe this is the first time a program of this type and magnitude has been done in an ongoing pension plan," said Bob Shanks, Ford's chief financial officer.
BUSINESS
October 30, 2011 | Ken Bensinger, Los Angeles Times
First of three parts Tiffany Lee wanted a car. She was weary of the two-hour bus ride to her job at a UCLA Health System clinic. She hated having to ask friends to drive her 7-year-old son to his asthma treatments. But as a single mother with three children, bad credit and a $27,000-a-year salary, she couldn't find a bank or dealership willing to give her a loan. Then a friend steered her to Repossess Auto Sales in Hawthorne. Another buyer might have balked at the deal she was offered.
BUSINESS
August 7, 2011 | By Kenneth R. Harney
If you give millions of seriously underwater homeowners a new equity position in their properties by reducing their principal mortgage debt, will they keep paying on their loans and avoid foreclosure? Call it a pipe dream or a significant model for other lenders and investors, but one company says it has found an important combination: Modify underwater borrowers' loans so that their payments are reduced to a manageable amount and cut their principal debt over time, but make the deal dependent on their scrupulous on-time monthly payments of the new amount plus sharing of a portion of any future profit they make on the house sale.
HEALTH
March 22, 2012 | By Melissa Healy, Los Angeles Times
Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. Now, a new pill formulated by a respected pharmaceutical company and approved by the Food and Drug Administration will do little to help most patients and will bring misery to some, say two medical investigators. The drug, Aricept 23 mg, is no more effective on the whole than the disappointing ones already on the market - but is more likely to cause gastrointestinal problems, wrote Drs. Steven Woloshin and Lisa Schwartz of Dartmouth Medical College in an article published Thursday in the medical journal BMJ. The new formulation was devised to serve commercial objectives, they say, and was approved despite a poor showing in company-sponsored tests.
BUSINESS
February 14, 2010 | Kathy M. Kristof, Personal Finance
If you are a teacher in debt, there's good news and bad news. There are literally dozens of programs that could potentially help wipe out your student loans. But most of them have narrow requirements that may lock you out. Just ask Troy Dale, a high school counselor from Ellis, Kan. He and his wife have $23,000 in student loans that they've been paying down for nearly a decade. At their current rate, they'll still be paying off their student debts when their oldest child enrolls in college.
BUSINESS
May 18, 2012 | Walter Hamilton, Jessica Guynn and Tiffany Hsu, Los Angeles Times
There wasn't much to like about Facebook's first day as a public company. The social media giant's stock rose by mere pennies in its initial public offering. The shares closed at $38.23, barely above the $38 IPO price. The performance fell far short of the grandiose expectations of Wall Street and Silicon Valley, and raised questions about whether the company's stock will be the sure bet many had counted on. "There was all this pressure and hype and attention with all eyes on Facebook — and the starlet tripped on the red carpet," said Max Wolff, an analyst at GreenCrest Capital Management in New York.